Active, Not Recruiting
Trastuzumab Deruxtecan (T-DXd) With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer (DESTINY-Breast09)
NCT04784715
- Conditions
- Breast Cancer; HER2-positive; Metastatic, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Research Site Tucson, Arizona, United States
- Research Site Springdale, Arkansas, United States
- Research Site Glendale, California, United States
- Research Site Glendale, California, United States